NCT02808988View on ClinicalTrials.gov

Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis

PHASE4CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Chronic Periodontitis
Interventions
PROCEDURE

periodontal phase 1 therapy

periodontal phase 1 therapy consisted of scaling and root planning with ultrasonic and hand instruments under local anesthesia and gingival crevicular fluid collection by the same investigator.

PROCEDURE

gingival crevicular fluid collection

gingival crevicular fluid collection by periopapers

OTHER

zoledronic acid

5 mg/year zoledronic acid (i.v.)

All Listed Sponsors
lead

Ondokuz Mayıs University

OTHER

NCT02808988 - Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis | Biotech Hunter | Biotech Hunter